Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab

Cancer Immunology, Immunotherapy · Published 2021-11-01 · Available online 1 Apr 2021 · Journal article · DOI 10.1007/s00262-021-02926-3 · PMID: 33796915 · PMC · Cited by 82 (Crossref)

Authors (4)

Wei-Xiang Qi, Yi Xiang, Shengguang Zhao, Jiayi Chen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

70

Issue

11

Pages

3199-3206

Year

2021

Citation

Qi, W., Xiang, Y., Zhao, S., et al. (2021). Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-021-02926-3

Related articles

• New insight in early detection and precision medicine in small cell lung cancer: liquid biopsy as innovative clinical tool · Critical Reviews in Clinical Laboratory Sciences · 2025 · Cites or is cited by this article
• Prognostic impact of baseline blood biomarkers in SCLC first-line treatment. · 2025 · Cites or is cited by this article
• Inflammation markers in lung cancer: prognostic and predictive value · Monaldi Archives for Chest Disease · 2025 · Cites or is cited by this article
• Nutritional Indexes and Their Variations as Predictors of Atezolizumab Plus Chemotherapy Efficacy in Extensive-Stage Small Cell Lung Cancer: A Turkish Oncology Group Study · Journal of Immunotherapy · 2026 · Cites or is cited by this article
• Real‐World Prognostic Analysis of Clinical Characteristics in Extensive‐Stage Small Cell Lung Cancer: A Nomogram for Survival Prediction in Patients Receiving First‐Line Immunochemotherapy With Serplulimab · Cancer Medicine · 2026 · Cites or is cited by this article
• Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis · Cancer and Metastasis Reviews · 2025 · Cites or is cited by this article
• HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal

Metrics

Citations (Crossref)

82